SCHEMBL24129488

SCHEMBL24129488

CNNc1cccc(OC)n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.44
KDR P35968 1/20 0.44
TAAR1 Q96RJ0 1/20 0.43
ITGB1 P05556 1/20 0.42
ITGA4 P13612 1/20 0.42
TRPV4 Q9HBA0 1/20 0.40
TSPO P30536 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
OPRM1 P35372 1/20 0.39
RPS6KA2 Q15349 1/20 0.39
SORT1 Q99523 1/20 0.38
BTK Q06187 1/20 0.37
MAPK8 P45983 1/20 0.37
PHGDH O43175 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2468863 0.83 GRM5 (0.46) GRM5KDRTAAR1ITGB1ITGA4
Hydrochloric Acid SCHEMBL2942831 0.82 GRM5 (0.45) GRM5KDRTAAR1ITGB1ITGA4
SCHEMBL6071585 0.78 TAAR1 (0.48) GRM5KDRTAAR1ITGB1ITGA4
SCHEMBL930769 0.77 GRM5 (0.41) GRM5KDRALDH1A1
SCHEMBL24189390 0.75 ALDH1A1 (0.59) CYP1A2CYP2C19ALDH1A1
SCHEMBL160602 0.75 BTK (0.47) GRM5KDRBTKALDH1A1
SCHEMBL8348068 0.74 GRM5 (0.50) GRM5KDRTAAR1ITGB1ITGA4
SCHEMBL10829377 0.74 TAAR1 (0.49) GRM5KDRTAAR1ITGB1ITGA4
Bromide SCHEMBL3344723 0.72 GRM5 (0.41) GRM5KDRTAAR1TRPV4SORT1
SCHEMBL19151683 0.72 RAB9A (0.53) GRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141593-A2 PROCESS FOR SYNTHESIS OF GALBULIMIMA ALKALOID 18 AND COMPOUNDS USEFUL AS OPIOID RECEPTOR ANTAGONISTS AND AGONISTS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-27 WO disclosed
WO-2021257828-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2021-12-23 WO disclosed